Metastatic Colorectal Cancer
with EGFR Inhibitor Induced Acneiform Lesions
Epidermal Growth Factor Receptor Inhibitors (EGFRi) are commonly used and have been found to be successful in treating several types of cancers, including colorectal cancers. Even though they are highly effective, there are certain side effects, one of which includes skin lesions or rashes that look like acne. The acneiform rash appears primarily on the face, scalp, chest, and upper back.
Revive Research Institute is conducting a clinical trial on a new topical gel for the treatment of acneiform skin lesions caused by the EGFRi anti-cancer therapy. The purpose of the gel is to prevent worsening of the lesions as well as reduce their severity.
- Adults 18 years of age or older, male or female
- Must be diagnosed with metastatic colorectal cancer
- Must be treated with an EGFR Inhibitor such as Erbitux or Vecitibix
- Must have acneiform lesions
- Additional criteria may apply
Our group of licensed and certified physicians will be keeping track of the patient’s progress throughout the study and will address any concerns or queries that arise regarding the research trial. The investigational treatment is free for the duration of the clinical trial and insurance is not required. All patient records and information will be kept secure and confidential. The patient will also receive compensation for their time and involvement.